A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1
NCT00239187
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
E1 and G1
Sponsor
OPKO Health, Inc.